{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T12:52:31Z","timestamp":1781009551823,"version":"3.54.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007782","name":"Tshwane University of Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007782","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","award":["2U01FD004246-09"],"award-info":[{"award-number":["2U01FD004246-09"]}],"id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.phymed.2020.153416","type":"journal-article","created":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T04:45:44Z","timestamp":1605761144000},"page":"153416","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Modulation of CYP3A4 and CYP2C9 activity by Bulbine natalensis and its constituents: An assessment of HDI risk of B. natalensis containing supplements"],"prefix":"10.1016","volume":"81","author":[{"given":"Islam","family":"Husain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vamshi","family":"Manda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manal","family":"Alhusban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia R.","family":"Dale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Yeong","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bharathi","family":"Avula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bill J.","family":"Gurley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amar G.","family":"Chittiboyina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikhlas A.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shabana I.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2020.153416_bib0001","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1089\/jmf.2008.0221","article-title":"Effect of Bulbine natalensis baker stem extract on the functional indices and histology of the liver and kidney of male Wistar rats","volume":"12","author":"Afolayan","year":"2009","journal-title":"J Med Food"},{"key":"10.1016\/j.phymed.2020.153416_bib0002","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1021\/acs.jnatprod.9b00187","article-title":"Anthraquinone-based specialized metabolites from rhizomes of Bulbine natalensis","volume":"82","author":"Bae","year":"2019","journal-title":"J Nat Prod"},{"key":"10.1016\/j.phymed.2020.153416_bib0003","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1055\/a-1037-4051","article-title":"Development and validation of a UHPLC-PDA-MS Method for the quantitative analysis of anthraquinones in Bulbine natalensis extracts and dietary supplements","volume":"86","author":"Bae","year":"2020","journal-title":"Planta Med"},{"key":"10.1016\/j.phymed.2020.153416_bib0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.toxlet.2018.07.023","article-title":"Essential oils of culinary herbs and spices activate PXR and induce CYP3A4 in human intestinal and hepatic in vitro models","volume":"296","author":"Bartonkova","year":"2018","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.phymed.2020.153416_bib0005","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/854015","article-title":"Interactions between CYP3A4 and dietary polyphenols","volume":"2015","author":"Basheer","year":"2015","journal-title":"Oxidative Med Cell Longev"},{"key":"10.1016\/j.phymed.2020.153416_bib0006","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1039\/b803784c","article-title":"Knipholone and related 4-phenylanthraquinones: structurally, pharmacologically, and biosynthetically remarkable natural products","volume":"25","author":"Bringmann","year":"2008","journal-title":"Nat Prod Rep"},{"key":"10.1016\/j.phymed.2020.153416_bib0009","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.phrs.2010.04.001","article-title":"Herbal interactions on absorption of drugs: mechanisms of action and clinical risk assessment","volume":"62","author":"Colalto","year":"2010","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.phymed.2020.153416_bib0011","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/9402781","article-title":"Pharmacokinetic interactions between cardiovascular medicines and plant products","author":"Costache","year":"2019","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.phymed.2020.153416_bib0013","series-title":"Medicinal Plants of South Africa","first-page":"64","author":"Dagne","year":"1997"},{"issue":"1","key":"10.1016\/j.phymed.2020.153416_bib0014","doi-asserted-by":"crossref","DOI":"10.3390\/jpm8010001","article-title":"Pharmacogenomics of CYP2C9: functional and clinical considerations","volume":"8","author":"Daly","year":"2018","journal-title":"J Pers Med"},{"key":"10.1016\/j.phymed.2020.153416_bib0016","doi-asserted-by":"crossref","first-page":"4967","DOI":"10.1021\/acs.jafc.9b00846","article-title":"Safety Assessment of Phytochemicals Derived from the Globalized South African Rooibos Tea (Aspalathus linearis) through Interaction with CYP, PXR, and P-gp","volume":"67","author":"Fantoukh","year":"2019","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.phymed.2020.153416_bib0017","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jpba.2019.05.065","article-title":"Biological activity and stability analyses of knipholoneanthrone, a phenyl anthraquinone derivative isolated from Kniphofia foliosa Hochst","volume":"174","author":"Feilcke","year":"2019","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.phymed.2020.153416_bib0018","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1080\/00498250601050412","article-title":"Attenuating pregnane X receptor (PXR) activation: a molecular modelling approach","volume":"37","author":"Gao","year":"2007","journal-title":"Xenobiotica"},{"key":"10.1016\/j.phymed.2020.153416_bib0019","first-page":"1329","article-title":"The orphan human pregnane X receptor mediates the transcriptional activation of CYP3A4 by rifampicin through a distal enhancer module","volume":"56","author":"Goodwin","year":"1999","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.phymed.2020.153416_bib0020","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.tips.2016.05.006","article-title":"Recent structural insights into cytochrome P450 Function","volume":"37","author":"Guengerich","year":"2016","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.phymed.2020.153416_bib0021","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1055\/s-0031-1298273","article-title":"Pharmacokinetic herb-drug interactions (Part 1): origins, mechanisms, and the impact of botanical dietary supplements","volume":"78","author":"Gurley","year":"2012","journal-title":"Planta Medi"},{"key":"10.1016\/j.phymed.2020.153416_bib0022","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1055\/s-0031-1298331","article-title":"Pharmacokinetic herb-drug interactions (part 2): drug interactions involving popular botanical dietary supplements and their clinical relevance","volume":"78","author":"Gurley","year":"2012","journal-title":"Planta Med"},{"key":"10.1016\/j.phymed.2020.153416_bib0023","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/cpt.1131","article-title":"\u201c...Not intended to diagnose, treat, cure, or prevent any disease.\u201d 25 years of botanical dietary supplement research and the lessons learned","volume":"104","author":"Gurley","year":"2018","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.phymed.2020.153416_bib0007","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.bbadis.2011.01.014","article-title":"Nuclear Receptor PXR, transcriptional circuits and metabolic relevance","volume":"1812","author":"Ihunnah","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.phymed.2020.153416_bib0025","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1172\/JCI3703","article-title":"The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions","volume":"102","author":"Lehmann","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.phymed.2020.153416_bib0026","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/toxsci\/kfj173","article-title":"Identification of new human pregnane X receptor ligands among pesticides using a stable reporter cell system","volume":"91","author":"Lemaire","year":"2006","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.phymed.2020.153416_bib0028","doi-asserted-by":"crossref","first-page":"10964","DOI":"10.1021\/acs.jafc.8b03372","article-title":"Oleanolic acid inhibits liver X Receptor Alpha and Pregnane X Receptor to Attenuate ligand-induced lipogenesis","volume":"66","author":"Lin","year":"2018","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.phymed.2020.153416_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2020.111313","article-title":"Liver toxicity of anthraquinones: A combined in vitro cytotoxicity and in silico reverse dosimetry evaluation","volume":"140","author":"Liu","year":"2020","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.phymed.2020.153416_bib0030","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1124\/dmd.30.7.795","article-title":"CYP3A4 induction by drugs: correlation between a pregnane X receptor reporter gene assay and CYP3A4 expression in human hepatocytes","volume":"30","author":"Luo","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.phymed.2020.153416_bib0031","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1002\/ptr.5942","article-title":"PXR mediated induction of CYP3A4, CYP1A2, and P-gp by Mitragyna speciosa and its alkaloids","volume":"31","author":"Manda","year":"2017","journal-title":"Phytother Res"},{"key":"10.1016\/j.phymed.2020.153416_bib0032","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3109\/00498254.2015.1053006","article-title":"Inhibition of CYP3A4 and CYP1A2 by Aegle marmelos and its constituents","volume":"46","author":"Manda","year":"2016","journal-title":"Xenobiotica"},{"key":"10.1016\/j.phymed.2020.153416_bib0033","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2014.00178","article-title":"Evaluation of drug interaction potential of Labisia pumila (Kacip Fatimah) and its constituents","volume":"5","author":"Manda","year":"2014","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.phymed.2020.153416_bib0034","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1055\/s-0042-103689","article-title":"Modulation of CYPs, P-gp, and PXR by Eschscholzia californica (California Poppy) and its alkaloids","volume":"82","author":"Manda","year":"2016","journal-title":"Planta Med"},{"key":"10.1016\/j.phymed.2020.153416_bib0010","first-page":"150","article-title":"Review of studies on Bulbine natalensis Baker (Asphodelaceae): Ethnobotanical uses, biological and chemical properties","volume":"10","author":"Musara","year":"2020","journal-title":"J Appl Pharm"},{"key":"10.1016\/j.phymed.2020.153416_bib0036","doi-asserted-by":"crossref","first-page":"5366","DOI":"10.1021\/jf073350e","article-title":"Activation of Pregnane X Receptor and induction of MDR-1 by dietary phytochemicals","volume":"56","author":"Satsu","year":"2008","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.phymed.2020.153416_bib0037","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1124\/dmd.115.066902","article-title":"Pharmacokinetic interactions between drugs and botanical dietary supplements","volume":"44","author":"Sprouse","year":"2016","journal-title":"Drug Metab Dispos"},{"issue":"4","key":"10.1016\/j.phymed.2020.153416_bib0039","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.sajb.2011.08.011","article-title":"The potential of South African plants in the development of new medicinal products","volume":"77","author":"Van Wyk","year":"2011","journal-title":"S Afr J Bot"},{"key":"10.1016\/j.phymed.2020.153416_bib0040","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0305-1978(94)00094-W","article-title":"Chemotaxonomic significance of anthraquinones in the roots of asphodeloideae (asphodelaceae)","volume":"23","author":"VanWyk","year":"1995","journal-title":"Biochem Syst Ecol"},{"key":"10.1016\/j.phymed.2020.153416_bib0041","doi-asserted-by":"crossref","first-page":"781","DOI":"10.2174\/138920009789895480","article-title":"Genetic polymorphism of the human cytochrome P450 2C9 gene and its clinical significance","volume":"10","author":"Wang","year":"2009","journal-title":"Curr Drug Metab"},{"key":"10.1016\/j.phymed.2020.153416_bib0042","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1182\/blood-2012-06-436691","article-title":"The constitutive androstane receptor is a novel therapeutic target facilitating cyclophosphamide-based treatment of hematopoietic malignancies","volume":"121","author":"Wang","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.phymed.2020.153416_bib0044","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0022-2836(03)00795-2","article-title":"Coactivator binding promotes the specific interaction between ligand and the pregnane X receptor","volume":"331","author":"Watkins","year":"2003","journal-title":"J Mol Biol"},{"key":"10.1016\/j.phymed.2020.153416_bib0045","first-page":"1430","article-title":"A crystal structure of human PXR in complex with the St","volume":"42","author":"Watkins","year":"2003","journal-title":"John's wort compound hyperforin. Biochemistry"},{"key":"10.1016\/j.phymed.2020.153416_bib0046","doi-asserted-by":"crossref","first-page":"7739","DOI":"10.1074\/jbc.R100033200","article-title":"Orphan nuclear receptors: the exotics of xenobiotics","volume":"276","author":"Xie","year":"2001","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.phymed.2020.153416_bib0047","doi-asserted-by":"crossref","first-page":"568","DOI":"10.3109\/13880200903207094","article-title":"Anabolic and androgenic activities of Bulbine natalensis stem in male Wistar rats","volume":"48","author":"Yakubu","year":"2010","journal-title":"Pharm Biol"},{"key":"10.1016\/j.phymed.2020.153416_bib0048","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1365-2605.2008.00910.x","article-title":"Effect of aqueous extract of Bulbine natalensis (Baker) stem on the sexual behaviour of male rats","volume":"32","author":"Yakubu","year":"2009","journal-title":"Int J Androl"},{"issue":"5","key":"10.1016\/j.phymed.2020.153416_bib0051","doi-asserted-by":"crossref","first-page":"754","DOI":"10.3109\/14756366.2015.1063623","article-title":"Anthraquinone profile, antioxidant and enzyme inhibitory effect of root extracts of eight Asphodeline taxa from Turkey: can Asphodeline roots be considered as a new source of natural compounds?","volume":"31","author":"Zengin","year":"2016","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.phymed.2020.153416_bib0008","unstructured":"US-FDA guideline 2017. Clinical drug interaction studies-study design, data analysis, and clinical implications guidance for industry. http:\/\/www.fda.gov\/Drugs\/Guidance Compliance Regulatory Information\/Guidances\/default.htm."}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711320302476?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711320302476?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T18:26:16Z","timestamp":1760552776000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711320302476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":42,"alternative-id":["S0944711320302476"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2020.153416","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modulation of CYP3A4 and CYP2C9 activity by Bulbine natalensis and its constituents: An assessment of HDI risk of B. natalensis containing supplements","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2020.153416","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"153416"}}